2019 Annual Meeting | C208 - Contemporary Concerns About Brain Death Determination

Date Thursday 05/09/19

Time 07:00 AM - 09:00 AM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ariane Lewis, MD, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Course attendees will be knowledgeable about the AAN's guidelines for declaration of brain death; contemporary clinical, ethical and legal challenges to brain death determination; and the AAN Brain Death Working Group's actions and recommendations to approach, avoid, and abrogate these controversies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM EDT	Speaker	Introduction Ariane Lewis, MD, FAAN
07:05 AM - 07:35 AM EDT	Speaker	Guideline Content and Variability David M. Greer, MD, FAAN
07:35 AM - 08:00 AM EDT	Speaker	Brain Death and the Law Ariane Lewis, MD, FAAN
08:00 AM - 08:25 AM EDT	Speaker	Brain Death and Society: Familial Objections to Use of Neurologic Criteria to Declare Death Matthew Kirschen, MD, PhD, FAAN
08:25 AM - 08:50 AM EDT	Speaker	The Brain Death Working Group James A. Russell, DO, FAAN
08:50 AM - 09:00 AM EDT	Speaker	Questions

Faculty Disclosures
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. An immediate family member of Dr. Greer has or had stock in Vertex Pharmaceuticals. The institution of Dr. Greer has received research support from NINDS. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Matthew Kirschen, MD, PhD, FAAN	The institution of Dr. Kirschen has received research support from NIH.
James A. Russell, DO, FAAN	Dr. Russell has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��